Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2015

May 18, 2015

34395_dirs_2015-05-18_60fcfce8-c9ce-4a7d-bde7-40e613bb8b16.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-05-15

Reporting Person: Reynolds Cameron John (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-15 Common Stock P 1400 $3.3199 Acquired 1103744 Direct
2015-05-15 Common Stock P 100 $3.4099 Acquired 1103844 Direct